Central Nervous System News and Research

RSS

Study explores the mediatory role of gut microbiota in metabolic syndrome and sleep disorders

Researchers described gut microbiota and metabolic alterations common to metabolic syndrome (MetS) and sleep disorders.

31 Jan 2024

Fermented foods linked to mental health benefits through gut-brain connection

Researchers explore the mental health benefits of fermented foods on the microbiota-gut-brain axis, highlighting the need for further studies to understand their therapeutic potential.

29 Jan 2024

Study identifies plasma markers linked to mental health in young adults

Study in "Translational Psychiatry" explores plasma proteins related to the p-factor in young adults, revealing potential biomarkers for overall mental health status and insights into common underlying factors of mental health disorders.

28 Jan 2024

Low-dose radiation shows promise as treatment for brain injury and stroke

Traumatic brain injury (TBI) and ischemic stroke are major public health concerns and leading causes of death and disability worldwide.

27 Jan 2024

From gut to brain: How diet can influence Alzheimer's and Parkinson's outcomes

Diet modification and alterations in the intestinal microbial population could impact the disease course of Alzheimer’s and Parkinson’s diseases.

23 Jan 2024

Long COVID and ME/CFS patients could benefit from a coordinated treatment strategy

People suffering from Long COVID or Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new University of Otago study has found.

22 Jan 2024

Scientists discover key brain cells affected by COVID-19

A recent Cell Stem Cell study investigated whether SARS-CoV-2 infection leads to dopaminergic neuron senescence.

22 Jan 2024

Using AI to break the opioid addiction cycle

When Ben Brown, research assistant professor of chemistry, thinks about the opioid epidemic, he views the problem on a molecular level.

19 Jan 2024

AI scores breakthrough in anemia treatment with novel PHD inhibitor

Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine ("InSilico"), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal focusing on critical studies about molecular structure and biological activity, has published the company's discovery of a novel PHD inhibitor for the treatment of anemia.

19 Jan 2024

Insilico Medicine leverages AI to identify promising new target for breast and gynecological cancers

Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven drug discovery company, recently published an early research that it has identified MYT1 as a promising new therapeutic target for breast and gynecological cancer, and discovered a series of novel, potent, and highly selective inhibitors specifically targeting MYT1.

19 Jan 2024

You rarely see them and might not even remember being bitten, but ticks can pose a serious threat, reveals study

The prevalence of common tick-borne diseases (TBDs) among Johnston County citizens.

16 Jan 2024

Research reveals the function of a little-understood junction between brain cells

New research from Oregon Health & Science University for the first time reveals the function of a little-understood junction between cells in the brain that could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer's disease, to a type of brain cancer known as glioma.

12 Jan 2024

University of Oxford launches first-in-human trial of the ChAdOx1 NipahB vaccine

The University of Oxford has launched a new clinical trial to test a vaccine to protect people against deadly Nipah virus.

11 Jan 2024

Alzheimer's disease found to have five distinct subtypes

Researchers identified five distinct molecular subtypes of Alzheimer's disease using proteomic sequencing, suggesting personalized treatment approaches based on each subtype's unique genetic and pathological characteristics.

10 Jan 2024

Blocking brain inflammation could slow, reverse ALS symptoms

In people with amyotrophic lateral sclerosis (ALS), changes in neurons appear to activate immune cells. Lowering the inflammation could reduce the symptoms of the disease, according to a study led by Chantelle Sephton, a professor at Université Laval's Faculty of Medicine.

10 Jan 2024

Central Nervous System News and Research

Study explores the mediatory role of gut microbiota in metabolic syndrome and sleep disorders

Fermented foods linked to mental health benefits through gut-brain connection

Study identifies plasma markers linked to mental health in young adults

Low-dose radiation shows promise as treatment for brain injury and stroke

From gut to brain: How diet can influence Alzheimer's and Parkinson's outcomes

Long COVID and ME/CFS patients could benefit from a coordinated treatment strategy

Scientists discover key brain cells affected by COVID-19

Using AI to break the opioid addiction cycle

AI scores breakthrough in anemia treatment with novel PHD inhibitor

Insilico Medicine leverages AI to identify promising new target for breast and gynecological cancers

You rarely see them and might not even remember being bitten, but ticks can pose a serious threat, reveals study

Research reveals the function of a little-understood junction between brain cells

University of Oxford launches first-in-human trial of the ChAdOx1 NipahB vaccine

Alzheimer's disease found to have five distinct subtypes

Blocking brain inflammation could slow, reverse ALS symptoms

Study: Respiratory syncytial virus directly infects nerve cells and causes inflammation

Widespread pain makes exercise a challenge for some patients with multiple sclerosis

AI model predicts aging and disease risk using facial and retinal images

Using machine learning to predict disease progression in multiple sclerosis

Breakthrough in gene editing: Enhanced virus-like particles promise new era in genetic disease treatment

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News